TY - JOUR
T1 - Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy
AU - Jaikuna, Tanwiwat
AU - Osorio, Eliana Vasquez
AU - Azria, David
AU - Chang-Claude, Jenny
AU - De Santis, Maria Carmen
AU - Gutiérrez-Enríquez, Sara
AU - van Herk, Marcel
AU - Hoskin, Peter
AU - Lambrecht, Maarten
AU - Lingard, Zoe
AU - Seibold, Petra
AU - Seoane, Alejandro
AU - Sperk, Elena
AU - Symonds, R. Paul
AU - Talbot, Christopher J.
AU - Rancati, Tiziana
AU - Rattay, Tim
AU - Reyes, Victoria
AU - Rosenstein, Barry S.
AU - de Ruysscher, Dirk
AU - Vega, Ana
AU - Veldeman, Liv
AU - Webb, Adam
AU - West, Catharine M.L.
AU - Aznar, Marianne C.
N1 - Funding Information:
REQUITE received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 601826. We thank all patients who participated in the REQUITE study and all study personnel involved in the REQUITE project. Marianne Aznar acknowledges the support of the Engineering and Physical Sciences Research Council (Grant number EP/T028017/1), This work was supported by Cancer Research UK RadNet Manchester [C1994/A28701] and the NIHR Manchester Biomedical Research Centre (NIHR203308). The researchers at DKFZ also thank Anusha Müller, Irmgard Helmbold, Thomas Heger, Sabine Behrens, Juan Camilo Rosas. Petra Seibold was supported by ERA PerMed 2018 funding (BMBF #01KU1912) and BfS funding (#3619S42261). S. Gutiérrez-Enríquez is supported by the Government of Catalonia 2021SGR01112. The VHIO authors acknowledge the Cellex Foundation for providing research equipment and facilities and thank CERCA Program/Generalitat de Catalunya for institutional support.
Funding Information:
Marianne Aznar acknowledges the support of the Engineering and Physical Sciences Research Council (Grant number EP/T028017/1)
Funding Information:
REQUITE received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 601826.
Funding Information:
The researchers at DKFZ also thank Anusha Müller, Irmgard Helmbold, Thomas Heger, Sabine Behrens, Juan Camilo Rosas. Petra Seibold was supported by ERA PerMed 2018 funding (BMBF #01KU1912 ) and BfS funding ( #3619S42261 ).
Funding Information:
S. Gutiérrez-Enríquez is supported by the Government of Catalonia 2021SGR01112.
Funding Information:
This work was supported by Cancer Research UK RadNet Manchester [ C1994/A28701 ] and the NIHR Manchester Biomedical Research Centre ( NIHR203308 ).
Publisher Copyright:
© 2023
PY - 2023/12/1
Y1 - 2023/12/1
N2 - Background: Normal tissue complication probability (NTCP) models can be useful to estimate the risk of fibrosis after breast-conserving surgery (BCS) and radiotherapy (RT) to the breast. However, they are subject to uncertainties. We present the impact of contouring variation on the prediction of fibrosis. Materials and methods: 280 breast cancer patients treated BCS-RT were included. Nine Clinical Target Volume (CTV) contours were created for each patient: i) CTV_crop (reference), cropped 5 mm from the skin and ii) CTV_skin, uncropped and including the skin, iii) segmenting the 95% isodose (Iso95%) and iv) 3 different auto-contouring atlases generating uncropped and cropped contours (Atlas_skin/Atlas_crop). To illustrate the impact of contour variation on NTCP estimates, we applied two equations predicting fibrosis grade = 2 at 5 years, based on Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) models, respectively, to each contour. Differences were evaluated using repeated-measures ANOVA. For completeness, the association between observed fibrosis events and NTCP estimates was also evaluated using logistic regression. Results: There were minimal differences between contours when the same contouring approach was followed (cropped and uncropped). CTV_skin and Atlas_skin contours had lower NTCP estimates (-3.92%, IQR 4.00, p < 0.05) compared to CTV_crop. No significant difference was observed for Atlas_crop and Iso95% contours compared to CTV_crop. For the whole cohort, NTCP estimates varied between 5.3% and 49.5% (LKB) or 2.2% and 49.6% (RS) depending on the choice of contours. NTCP estimates for individual patients varied by up to a factor of 4. Estimates from “skin” contours showed higher agreement with observed events. Conclusion: Contour variations can lead to significantly different NTCP estimates for breast fibrosis, highlighting the importance of standardising breast contours before developing and/or applying NTCP models.
AB - Background: Normal tissue complication probability (NTCP) models can be useful to estimate the risk of fibrosis after breast-conserving surgery (BCS) and radiotherapy (RT) to the breast. However, they are subject to uncertainties. We present the impact of contouring variation on the prediction of fibrosis. Materials and methods: 280 breast cancer patients treated BCS-RT were included. Nine Clinical Target Volume (CTV) contours were created for each patient: i) CTV_crop (reference), cropped 5 mm from the skin and ii) CTV_skin, uncropped and including the skin, iii) segmenting the 95% isodose (Iso95%) and iv) 3 different auto-contouring atlases generating uncropped and cropped contours (Atlas_skin/Atlas_crop). To illustrate the impact of contour variation on NTCP estimates, we applied two equations predicting fibrosis grade = 2 at 5 years, based on Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) models, respectively, to each contour. Differences were evaluated using repeated-measures ANOVA. For completeness, the association between observed fibrosis events and NTCP estimates was also evaluated using logistic regression. Results: There were minimal differences between contours when the same contouring approach was followed (cropped and uncropped). CTV_skin and Atlas_skin contours had lower NTCP estimates (-3.92%, IQR 4.00, p < 0.05) compared to CTV_crop. No significant difference was observed for Atlas_crop and Iso95% contours compared to CTV_crop. For the whole cohort, NTCP estimates varied between 5.3% and 49.5% (LKB) or 2.2% and 49.6% (RS) depending on the choice of contours. NTCP estimates for individual patients varied by up to a factor of 4. Estimates from “skin” contours showed higher agreement with observed events. Conclusion: Contour variations can lead to significantly different NTCP estimates for breast fibrosis, highlighting the importance of standardising breast contours before developing and/or applying NTCP models.
KW - Breast cancer
KW - Fibrosis
KW - Inter-observer variation
KW - Late effects
KW - NTCP modelling
KW - Radiotherapy
U2 - 10.1016/j.breast.2023.103578
DO - 10.1016/j.breast.2023.103578
M3 - Article
SN - 0960-9776
VL - 72
JO - Breast
JF - Breast
IS - 1
M1 - 103578
ER -